Skip to main content
Log in

An elderly patient with advanced lung cancer achieved long-term survival using Chinese medicine: An alternative treatment strategy for cancer patients aged 80 or older without a tissue confirmed diagnosis

  • Case Report
  • Published:
Chinese Journal of Integrative Medicine Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Chen WQ, Zhang SW, Zou XN. Evaluation on the incidence, mortality and tendency of lung cancer in China. Thoracic Cancer 2010;1:35–40.

    Article  Google Scholar 

  2. Chen WQ, Armstrong BK, Zheng RS, Zhang SW, Yu XQ, Clements M. Cancer burden in China: a Bayesian approach. BMC Cancer 2013;13:458.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Goss PE, Strasser-Weippl K, Lee-Bychkovsky BL, Fan L, Li J, Chavarri-Guerra Y, et al. Challenges to effective cancer control in China, India, and Russia. Lancet Oncol 2014;15:489–538.

    Article  PubMed  Google Scholar 

  4. Giroh L, Yu T, Sun WJ. Chinese cancer status—challenge and opportunity. Enliven: Challenges Cancer 2014;1(1):e001.

    Google Scholar 

  5. Xu W, Towers AD, Li P, Collet JP. Traditional Chinese medicine in cancer care: perspectives and experiences of patients and professionals in China. Eur J Cancer Care (Engl) 2006;15(4):397–403.

    Article  CAS  Google Scholar 

  6. Chen YM, Perng RP, Chen MC, Tsai CM, Ming-Liu J, Whang-Peng J. A phase I trial of vinorelbine plus gemcitabine in previously untreated inoperable (stage) non-small-cell lung cancer patients aged 80 or older. Lung Cancer 2003;40:221–226.

    Article  PubMed  Google Scholar 

  7. Kawaguchi T, Tamiya A, Tamura A, Arao M, Saito R, Matsumura A, et al. Chemotherapy is beneficial for elderly patients with advanced non-small-cell lung cancer: analysis of patients aged 70–74, 75–79, and 80 or older in Japan. Clin Lung Cancer 2012;13:442–447.

    Article  PubMed  Google Scholar 

  8. Altundag O, Stewart DJ, Fossella FV, Ayers GD, Wei W, Zhou X, et al. Many patients 80 years and older with advanced non-small cell lung cancer (NSCLC) can tolerate chemotherapy. J Thorac Oncol 2007;2:141–146.

    Article  PubMed  Google Scholar 

  9. Deng GE, Rausch SM, Jones LW, Gulati A, Kumar NB, Greenlee H, et al. Complementary therapies and integrative medicine in lung cancer. Diagnosis and management of lung cancer, 3rd ed. American College of Chest Physicians evidence-based clinical practice guidelines. Chest 2013;143:(5 Suppl):e420S–e436S.

    CAS  Google Scholar 

  10. Breen D, Barlesi F, Zemerli M, Doddoli C, Torre JP, Thomas P, et al. Results and impact of routine assessment of comorbidity in elderly patients with non-small-cell lung cancer aged > 80 years. Clin Lung Cancer 2007;8:331–334.

    Article  PubMed  Google Scholar 

  11. Ayyappan S, Gonzalez C, Yarlagadda R, Zakharia Y, Woodlock TJ. Lung cancer in the very elderly: incidence, presentation, and diagnostic decision-making. A retrospective analysis at a teaching community hospital. J Community Hosp Intern Med Perspect 2011;1:7313.

    Google Scholar 

  12. Wong R, Sagar CM, Sagar SM. Integration of Chinese medicine into supportive cancer care: a modern role for an ancient tradition. Cancer Treat Rev 2001;27:235–246.

    Article  CAS  PubMed  Google Scholar 

  13. Ruan WJ, Lai MD, Zhou JG. Anticancer effects of Chinese herbal medicine, science or myth? J Zhejiang Univ Sci B 2006;7:1006–1014.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Sun Y. The role of Chinese medicine in clinical oncology. Chin J Integr Med 2014;20:3–10.

    Article  CAS  PubMed  Google Scholar 

  15. Wang T, Xuan X, Li M, Gao P, Zheng Y, Zang W, et al. Astragalus saponins affect proliferation, invasion and apoptosis of gastric cancer BGC-823 cells. Diagn Pathol 2013;8:179.

    Article  PubMed  PubMed Central  Google Scholar 

  16. Liu Y, Ye F, Qiu GQ, Zhang M, Wang R, He QY, et al. Effects of lactone I from Atractylodes macrocephala Koidz on cytokines and proteolysis-inducing factors in cachectic cancer patients. J First Mil Med Univ (Chin) 2005;25:1308–1311.

    CAS  Google Scholar 

  17. Cheng S, Eliaz I, Lin J, Thyagarajan-Sahu A, Sliva D. Triterpenes from Poria cocos suppress growth and invasiveness of pancreatic cancer cells through the downregulation of MMP-7. Int J Oncol 2013;42:1869–1874.

    CAS  PubMed  PubMed Central  Google Scholar 

  18. Hung JY, Yang CJ, Tsai YM, Huang HW, Huang MS. Antiproliferative activity of paeoniflorin is through cell cycle arrest and the Fas/Fas ligand-mediated apoptotic pathway in human non-small cell lung cancer A549 cells. Clin Exp Pharmacol Physiol 2008;35:141–147.

    Article  CAS  PubMed  Google Scholar 

  19. Liu LL, Chen J, Shi YP. Advances in studies on antitumor of Chinese materia medica with heat-clearingand toxinresolving functions. Chin Tradit Herbal Drug (Chin) 2012;43:1203–1210.

    CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Bao-jin Hua  (花宝金).

Additional information

Supported by the National Natural Science Foundation of China (No. 81273718 and No. 81102719)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Liu, R., He, Sl., Hirasaki, Y. et al. An elderly patient with advanced lung cancer achieved long-term survival using Chinese medicine: An alternative treatment strategy for cancer patients aged 80 or older without a tissue confirmed diagnosis. Chin. J. Integr. Med. 22, 545–548 (2016). https://doi.org/10.1007/s11655-015-2309-9

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11655-015-2309-9

Keywords

Navigation